Tuesday, November 19, 2024
- 11:00AM-12:30PM
-
Abstract Number: 2687
Therapeutic Choices in Systemic Sclerosis Associated Interstitial Lung Disease, a Survey of International Experts
Abstracts: Systemic Sclerosis & Related Disorders – Clinical III- 11:00AM-12:30PM
-
Abstract Number: 2680
Thrombocytopenia in Patients with Systemic Lupus ErythematosusReal-World Data Based on a Nationwide Database, RISE
Abstracts: SLE – Diagnosis, Manifestations, & Outcomes III: Targets, Outcomes & Comorbidity- 11:00AM-12:30PM
-
Abstract Number: 2676
Timeframe for Initiating Methotrexate and Vaccine Response Against Pneumococcus in Rheumatoid Arthritis: The VACIMRA Study
Abstracts: RA – Treatment II: Refining Use of Established Therapies- 11:00AM-12:30PM
-
Abstract Number: 2691
Transcriptomic Changes in CD4+ T Lymphocytes in Eosinophilic Granulomatosis with Polyangiitis
Abstracts: Vasculitis – ANCA-Associated II- 11:00AM-12:30PM
-
Abstract Number: 2692
Transcriptomic Profiling of Kidney Biopsies Implicates Th17 and IL-17 in ANCA-Associated Vasculitis